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Abstract :
Survival rates in oesophageal atresia patients have reached over 90%. In long-term follow-up studies the 
focus has shifted from purely surgical or gastrointestinal evaluation to a multidisciplinary approach. We 
reviewed the literature on the long-term morbidity of these patients and discuss mainly issues of physical 
growth and neurodevelopment. We conclude that growth problems – both stunting and wasting – are 
frequently seen, but that sufficient longitudinal data are lacking. Therefore, it is unclear whether catch-up 
growth into adolescence and adulthood occurs. Data on determinants of growth retardation are also lacking 
in current literature. Studies on neurodevelopment beyond preschool age are scarce but oesophageal atresia 
patients seem at risk for academic problems and motor function delay. Many factors contribute to the 
susceptibility to growth and development problems and we propose a multidisciplinary follow-up schedule 
into adulthood future care which may help improve quality of life.
Keywords: oesophageal atresia, outcome, growth, motor function, neurodevelopment, cognition
Eductional aims:
After reading this review readers will be able to 
 recognize risk factors for long-term morbidity in oesophageal atresia patients
 describe long-term problems with respect to growth and neurodevelopment in oesophageal 
atresia patients
 mention topics that should be addressed at various stages of life in long-term multidisciplinary 
follow-up of oesophageal atresia patients
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
Introduction
Oesophageal atresia (OA) is a rare congenital anatomical anomaly with a prevalence of 1 in 2,500 to 4,500
live births(1). Gross in 1953 already described the classification of the different types; the most common is 
type C with a distal tracheo-oesophageal fistula (TOF), which occurs in 85-90%(2). In the 1950s and 1960s the 
neonatal mortality rates were approximately 35%; severe bronchopneumonia was the main cause of 
death(3). Due to better surgical techniques and intensive care treatment, mortality has dropped to less than 
10% today (4, 5), with severe associated chromosomal defects and complex cardiac defects as main causes 
of death. With decreasing mortality rates attention has shifted towards long-term morbidity.
The most common problems in OA-patients are: gastrointestinal morbidities (e.g. feeding difficulties, gastro-
oesophageal reflux disease (GORD), dysphagia), respiratory problems (e.g. lower respiratory tract infections, 
restrictive lung function, impaired exercise tolerance), impaired physical growth, and neurodevelopmental 
delays. This review will focus on growth and neurodevelopment, and the importance of longitudinal 
multidisciplinary long-term follow up.
Physical growth 
Long-term growth data
Growth has mainly been described in cross-sectional studies(6-11) and retrospective evaluations of medical 
charts(12-14). Gischler and co-workers evaluated longitudinal growth up till five years in a prospectively 
followed cohort of 23 OA-patients born from 1999 onwards; all but one patient had a type C-OA(15).
Although 26% of the patients needed prophylactic antibiotics to prevent airway infections, both height and 
weight corrected for age  increased between two and five years, but weight for age was still below the 
population norm at five years. The question is whether this trend of catch-up growth continues when the 
children get older. Meanwhile it has become known at 12 years of age growth had normalized in 22 of those 
23 patients: mean (SD) standard deviation score (SDS) height was -0.10 (1.12), and mean (SD) SDS weight for 
height was -0.22 (1.04) (unpublished data). 
Page 4 of 16
Ac
ce
pte
d M
an
us
cri
pt
4
Catch-up of height for age was also suggested by Andrassy and co-workers, who in 1983 published data on 
nutritional assessment in 53 cross-sectionally studied OA-patients – 83% with type C – aged 0.9 to 31 years. 
Chronic malnutrition – defined as height for age at least 2 SD below the norm – was significantly less 
prevalent in children 13 years and older than in those younger than 13 years (7.7 versus 22.5% of children, 
respectively)(6). This age relation was confirmed 10 years later – in 1993 - by Chetcuti and co-workers, who 
performed a cross-sectional study in 302 OA-patients aged 1 to 37 years (87% with type C; 164 of them were 
> 15 years). Adult OA-patients in that study had normal height and weight. Wasting, i.e. dec eased weight for 
height, was reported in 32% of patients < 5 years, 19% of patients aged 5-10 years, and 13% of children aged 
10-15 years(8).
In 2003, Little and co-workers published results of a chart review including 69 OA-patients – 77% with type C. 
At 5 years, height and weight were below the 5th percentile in 22 and 25%, respectively. Thirty-nine children 
were seen at the age of > 10 years; height was below the 5th percentile for 5 of those (12%) and weight was 
below the 5th percentile  for 7 of those (17%)(12). Lacher and co-workers performed a retrospective chart 
review of 80 OA-patients (79% with type C); only 46 of them were evaluated at 10 years. Weight for age was 
below the 3rd percentile for 20, 28 and 17% at the age of one year, six years, and 10 years respectively (13). 
These data suggest that growth problems persist even beyond the age of 10 years. 
In contrast, in two cross-sectional studies from different centres in Finland normal physical growth was 
reported in children with a mean age of 12 years studied several decades ago(7, 9), and Legrand and co-
workers recently even found overweight/obesity in 9% of 57 type C OA-patients studied at a mean age of 13 
years(10).
The most important results per age category are summarized in Table 1. Since most studies have a cross-
sectional or retrospective study design, conclusions on longitudinal growth cannot be drawn.
Prospective, longitudinal data collection is needed to describe growth profiles in OA-patients. Still, on the 
basis of the currently available literature it can be concluded that OA-patients are at risk for physical growth 
problems, especially within the first years of life, but that problems may persist even at older age. None of 
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the published long-term studies provides data on deviation from target height SDS. The target height is the 
expected adult height given the heights of the biological parents and corrected for secular trend(16).
Factors that influence long-term growth in OA
Children with OA have many problems that may affect long-term growth: recurrent surgical interventions, 
feeding difficulties, gastrointestinal problems, respiratory infections, associated congenital malformations, 
and genetic syndromes, among other things (Figure 1). Moreover, many are prematurely born or are small 
for gestational age (SGA)(4, 17). The current literature is not conclusive regarding the specific contributions
of these factors to growth. Many studies do not provide data on associated anomalies and proportions of 
prematurity and SGA. The presence of a long-gap OA is a risk factor for feeding problems and growth 
impairment(13, 18). In the study of Lacher and co-workers, weight of 6 of 14 long-gap OA-patients (43%) was 
below the 3rd percentile at 10 years of age(13). A recent paper  described persistent growth failure in 16 
long-gap OA patients up till the age of 7 years(19). Puntis and co-workers administered a standardized 
questionnaire regarding feeding difficulties to 230 members of the British parent support group. The 
response rate was  54%, data were obtained on patients  with a median age of 4 to 5 years (depending on 
type of OA). In 74% a primary anastomosis was performed and in 26% a delayed oesophageal substitution 
procedure. The median questionnaire scores did not differ between those two groups and the scores did not 
correlate with SDS for weight and height(18). In the study of Legrand and co-workers in type C OA-patients 
only a past history of GORD was a significant predictor of lower weight for SDS height(10); factors such as 
prematurity, SGA, actual GORD, fundoplication, or current respiratory problems did not affect long-term 
growth.
Neurodevelopmental outcome
The scarce data on neurodevelopmental outcome in OA-patients are summarized for  different age 
categories in Table 1. Worldwide, three centres have reported on prospective evaluation of
neurodevelopment within the first years of life(20-23). They used different versions of the Bayley Scales of 
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Infant Development and different reference groups. In all three studies the mental and psychomotor domain 
scores for non-syndromal OA-patients generally were within the normal ranges(20-22). In the study by 
Walker and co-workers, however, the mean score on language expression at one year was significantly 
below the norm (21). In that study, all other mean domain scores of OA-patients were slightly lower than the 
control scores although not significantly different(21). In the other two studies, too, the mean scores of the 
OA-patients never reached the population norm score of 100(20, 22). The meaning of this observation is not 
clear. Mazer and co-workers studied whether any factors within the first two years of life predicted cognition 
at five years of age in a cohort of 105 children with major non-cardiac congenital anomalies, including 15 OA-
patients. Significant predictors were the number of congenital anomalies and the mental developmental 
scores obtained within the first two years of life(24). Mazer and co-workers also concluded that 
psychomotor developmental scores in the first years of life were the only significant predictors of motor 
function at five years of age(24).
Thus far, only one published study addressed motor function in OA-patients beyond toddler age. Van der 
Cammen and co-workers studied motor function performance in a prospective cohort of 29 OA-patients 
without severe retardation or neurological impairments at the age of five years(23). Seven of these children 
(24%) received physical therapy at home. Motor function was normal in 19/29  children (66%), which is 
significantly less than the 85% expected from the Dutch reference data. Most problems were encountered 
with gross motor function (ball skills and balance skills) whereas manual dexterity was normal in 93% (versus 
85% expected) of them(23).
Only three cross-sectional studies on cognition in OA-patients at school age are available(7, 25, 26). In 1984, 
Lindahl reported normal intelligence at an age of 8.8 to 16.5 years (mean age 12.7 years) in a cohort of 33 
OA-patients born between 1966 and 1973. Compared with healthy Finnish children these patients had 
normal body-image but more anxiety problems(7).
In 1999, Bouman and co-workers reported a mean intelligence quotient (IQ) of 90.2 in 36 OA-patients aged 8 
to 12 years (mean age 10.2 years) ; this was significantly lower than that of the reference population. Thirty 
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percent of the study group had an IQ < 85. Their overall feelings of self-worth were normal. Neither their 
parents nor their teachers reported more behavioural problems compared to healthy peers(25).
Even less favourable data on long-term cognitive development have more recently been published by 
Kubota and co-workers: Mental retardation with IQ < 70 was observed in 25% of 20 OA-patients aged 6 to 17 
years. Furthermore, parents-reported behavioural problems within the clinical range for 35% of OA-patients. 
Unfortunately, the authors do not explain how these patients were recruited and therefore the possibility of
selection bias cannot be excluded(26).
Only three studies report on school performance. In the study of Bouman and co-workers, 22% of 36 OA-
patients received special education(25); this percentage was even higher in a study by Faugli and co-workers, 
i.e. 7 of 21 adolescents with OA (33%) (11). Lastly, Lacher and co-workers reported that 6 of 60 OA-patients 
(10%) who had reached school age received special education due to mental retardation (13).
Implications and future perspectives
As survival rates for OA have increased, more of these children will grow up into adulthood. Parents and care
providers will therefore need to pay attention to signs of long-term morbidity. A multidisciplinary approach 
with smooth transition of care from the paediatric to the adult care setting is essential in this context, as 
most of the problems of OA-patients are multifactorial and interact with each other.
With respect to growth the outcomes have hardly changed over the past 30 years. Still, we report growth 
failure especially in the first years of life without knowing its most important determinants. Findings from
cross-sectional studies suggest that catch-up growth occurs in adolescence and adulthood, but confirmatory 
longitudinal data are lacking. The current literature suggests that both height and weight are below normal. 
So, the question arises why this should be so. In the studies that have been published thus far, data on target 
height and growth deviation of target height SDS are not available. Are these children undernourished?
Standardized studies on energy expenditure have – as far as we know – not yet been performed in OA-
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patients. For future studies it may be worthwhile to include data on parental heights, making use of 
population-specific reference data.
The relationship between chronic malnutrition and cognition has been studied extensively during the past 
years and Corbett and Drewett performed a meta-analysis of these studies(27). They concluded that 
evidence from reasonably well-controlled studies indicates that failure to thrive in infancy is associated with 
adverse intellectual outcomes sufficiently large to be of importance at a population level(27). Some authors 
have suggested that the critical period of weight gain is within the first 8 weeks of life, and that weight 
faltering during that period predicts IQ at the age of 8 years(28). Although there is little evidence to 
recommend this for OA-patients, we still propose to start early and standardized nutritional assessment with 
dietary management within the first weeks of life, i.e. during the initial hospitalization. The next question 
that arises is whether nutritional interventions at older age are beneficial in OA-patients – taking into 
account the window of opportunity in early infancy and the fact that the available studies suggest catch-up 
growth in adolescence. Considering the differential timing of growth of body systems in humans, nutritional 
interventions at older age seem to be recommendable(29). We have to realize that most data on stunting in 
infancy and childhood  and the critical windows for its treatment with nutritional intervention have been 
obtained in underdeveloped countries(29). Nevertheless, the pubertal growth phase is considered as an 
additional window of opportunity for nutritional intervention(29). Dysphagia complaints have been reported 
in 44-61% of OA-patients during puberty(10, 30). Offering nutritional intervention to OA-patients in that 
phase of life may be challenging because puberty nowadays is characterized by increasing autonomy and 
importance of peer groups, and leaving well-controlled primary educational settings. Long-term follow up of 
growth and feeding difficulties in OA-patients is important; and timely interventions should be offered also if 
problems arise at later age. Actively asking about dysphagia, GORD, diet, and feeding habits may be helpful
in this respect. OA-patients may have altered perception of GORD, for example, because they have grown 
up with these symptoms(31). 
It seems that despite normal mental and psychomotor development in the first years of life(20-22), the need 
for special education among OA-patients is higher than in the normal population(11, 13, 25). The currently 
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available literature on mental health and development in OA-patients does not allow for explanations of this 
observation. Some issues that could be worthwhile to address in future care for OA-patients are speculated 
on here: Although OA-patients usually do not suffer from severe malnutrition, we should be aware that 
moderate malnutrition in infancy may lead to lower IQ, impaired academic achievement, or (subtle)
neuropsychological problems even into adulthood(32, 33).  Disturbed mother-child interaction, which has 
been described in OA-patients(34), may lead to insecure attachment with early relational trauma(35). This –
in its turn – could lead to maldevelopment of the right hemisphere(36). Studies in critically ill neonates have 
shown that eight-year-old survivors  concentration and school performance than peers, despite normal 
intelligence(37, 38). When children get older tasks get more complex and demanding. For those with more 
subtle developmental delays “growing into their deficits” is a realistic phenomenon(39) and may explain why 
– also in OA patients – developmental evaluations within the first years of life show scores within normal 
ranges. Ongoing prospective longitudinal follow-up programs should be continued with a focus on
neurodevelopmental evaluations at school age and beyond. These evaluations should not only assess 
cognition and academic achievement, but also executive functions, attention, language, sensorimotor 
functions, visuospatial processes, memory, and behaviour(40). Standardization and use of appropriate 
reference data or control groups is mandatory to draw conclusions and provide directions for improvement 
of care and intervention studies (Figure 1). As OA is a rare disease and case series are small, collaborative 
studies should be encouraged, also to evaluate the long-term effects of new surgical techniques on growth 
and development(41, 42).
In conclusion, this review suggests that children born with OA are at risk for growth failure,
neurodevelopmental delay, and school problems. There is every reason therefore to include them in long-
term multidisciplinary follow-up programs addressing a wide range of topics, many of which may interact. 
Outcome research should focus on collaborative multicentre projects with uniformity in assessment 
protocols and use of standardized instruments and data management.
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Table 1: Overview of long-term growth and (neuro)development outcomes
Infancy 
(< 2 yrs)
Preschool age 
(2-5 yrs)
School age 
(6-12 yrs)
Adolescence 
(>12 yrs)
Growth impaired weight, 
impaired height(13-
15, 22, 42)
impaired weight, 
impaired height(8, 
15, 18)
weight improves > 
10 yrs(8, 12, 13), 
height improves > 
10 yrs(12), normal 
growth(7, 9)
weight impaired(8, 
11),  height 
impaired(11), 
normal growth(6, 
7, 10)
(Neuro)developmental outcome
Motor function normal(20-22) abnormal in 34% at 
5 years(23)
unknown unknown
Cognition normal(20, 22), 
language 
expression scores 
low(21)
unknown normal(7), mild to 
moderate delay(25, 
26)
unknown
Neuropsychological 
tests
not applicable unknown unknown unknown
School 
performance
not applicable not applicable special education 
10-22%(13, 25)
special education 
33%(11)
Behaviour unknown unknown anxiety problems, 
behaviour in 
clinical range 
23%(26)
normal, anxiety 
problems, 
behaviour in 
clinical range 
23%(26)
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Table 2: Topics to be addressed at the various ages
Specific topics Relevance/intervention
Infancy Growth
Feeding difficulties/oral aversion
Psychosocial wellbeing
Gastro-oesophageal reflux
Dysphagia
Airway infections
Neurological impairment
Mental development
Motor development
Associated anomalies
Hyperalimentation
Referral preverbal speech-language pathologist
Psychological support
Drug therapy or anti-reflux surgery
Dilatation in case of stenosis
Antibiotic prophylactic therapy if indicated
Early recognition, rehabilitation, genetic 
counseling
Early recognition, rehabilitation, genetic 
counseling
Referral physical therapist
Organ-specific intervention if indicated 
Toddler/preschool age Growth 
Feeding difficulties/oral aversion
Psychosocial wellbeing
Gastro-oesophageal reflux
Dysphagia
Airway infections
Neurological impairment
Language development
Mental development
Motor function development
Associated anomalies
Hyperalimentation
Referral preverbal speech-language pathologist
Psychological support
Drug therapy or anti-reflux surgery
Early evaluation, management based on cause
Antibiotic prophylactic therapy if indicated
Rehabilitation, genetic counseling
Referral speech-language pathologist
Early recognition, rehabilitation, genetic 
counseling
Referral physical therapist
Organ-specific intervention if indicated
School age Growth 
Feeding difficulties/dysphagia
Gastro-oesophageal reflux
Motor function development
Neuropsychological assessment
Self esteem
Airway infections
Lung function assessment
Exercise capacity
Associated anomalies
Hyperalimentation, dietary advice
Management based on cause
Drug therapy or anti-reflux surgery
Referral physical therapist, sports participation
Early school support
Early intervention, support
Antibiotic prophylactic therapy if indicated
Evaluate reversibility of airflow obstruction
Exercise training, sports participation
Organ-specific intervention if indicated
Adolescence into 
adulthood
Growth
Feeding difficulties/dysphagia
Gastro-oesophageal reflux
Neuropsychological assessment
Self esteem
Exercise capacity
Associated anomalies
Transition to adult care
Hyperalimentation, dietary advice 
Management based on cause
Drug therapy or anti-reflux surgery
School support, choice of profession/career
Psychological support
Exercise training, sports participation
Organ-specific intervention and transition of 
care if indicated
Gastroenterology (endoscopic surveillance); 
clinical genetics (counseling)
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Figure 1: Standardized multidisciplinary approach to optimize care for oesophageal atresia patients 
GORD = gastro-oesophageal reflux disease
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Figure 1.
Screened for PRIMED
18,036
Eligible PRIMED Cases
16,839
Initial VT/VF rhythm
3,923
Non-Exclusions
3,046
Final Study Population
2,011     
Registry Cases Excluded
1,197
Specific Study Exclusions:
Trauma Etiology n = 8
PAD Shocks n = 64
EMS Witnessed n = 339
Missing Regression Variable Data n = 449
Missing Outcome Data n = 17
Missing CPR Quality Data, n = 1,028
Missing ROSC time n = 7
